Investing.com - Evotec SE ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Evotec SE ADR announced earnings per share of $0.06 on revenue of $177.27M. Analysts polled by Investing.com anticipated EPS of $0.21 on revenue of $188.75M.
Evotec SE ADR shares are up 86.39% from the beginning of the year , still down 66.23% from its 52 week high of $25.29 set on Wednesday, December 15, 2021.
Evotec SE ADR follows other major Healthcare sector earnings this month
Evotec SE ADR's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar